LifeMD Q3 revenue $60.2M (+13%), adj EBITDA $5.1M; paid off debt, sold WorkSimpli

LifeMD, Inc.

Total revenue $60.2M (+13% YoY); adjusted EBITDA $5.1M (+20% YoY).
Telehealth revenue $47.3M (+18% YoY); telehealth adjusted EBITDA $2.9M (+30% YoY).
Paid off all outstanding debt in Q3; divested majority stake in WorkSimpli after quarter end.
Pennsylvania 503-A compounding pharmacy approved; licensed in 14 states, pursuing 50-state license.
RexMD added nearly 10,000 net new subscribers; strong early traction in behavioral, women's, men's health.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.